Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $432,722 | 191 | 71.8% |
| Honoraria | $67,000 | 30 | 11.1% |
| Travel and Lodging | $42,708 | 197 | 7.1% |
| Consulting Fee | $34,215 | 19 | 5.7% |
| Food and Beverage | $25,477 | 923 | 4.2% |
| Education | $233.48 | 16 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $233,514 | 333 | $0 (2024) |
| Corcept Therapeutics | $130,428 | 154 | $0 (2022) |
| Amarin Pharma Inc. | $56,865 | 100 | $0 (2022) |
| Esperion Therapeutics, Inc. | $46,970 | 62 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $36,620 | 47 | $0 (2024) |
| Novo Nordisk Inc | $31,942 | 99 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $27,197 | 61 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $17,436 | 27 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $7,343 | 47 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $6,812 | 30 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302.74 | 16 | Amgen Inc. ($63.16) |
| 2023 | $6,508 | 23 | Esperion Therapeutics, Inc. ($6,238) |
| 2022 | $73,745 | 111 | Bayer HealthCare Pharmaceuticals Inc. ($29,009) |
| 2021 | $66,093 | 218 | Esperion Therapeutics, Inc. ($20,736) |
| 2020 | $47,971 | 86 | AstraZeneca Pharmaceuticals LP ($26,228) |
| 2019 | $127,264 | 289 | AstraZeneca Pharmaceuticals LP ($54,537) |
| 2018 | $132,662 | 304 | AstraZeneca Pharmaceuticals LP ($73,402) |
| 2017 | $147,809 | 329 | AstraZeneca Pharmaceuticals LP ($58,668) |
All Payment Transactions
1,376 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardio-renal | ||||||
| 11/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Diabetes Care | ||||||
| 05/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Cardio-renal | ||||||
| 03/13/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 03/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Diabetes | ||||||
| 03/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Inflammation | ||||||
| 02/14/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 02/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Inflammation | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Respiratory | ||||||
| 01/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes Care | ||||||
| 11/27/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Neuromodulation | ||||||
| 11/08/2023 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: INSOMNIA | ||||||
| 10/19/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Neuromodulation | ||||||
| 10/17/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 10/03/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Cardiology | ||||||
| 08/28/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 172 | 384 | $131,679 | $40,727 |
| 2022 | 11 | 1,088 | 7,005 | $117,274 | $41,071 |
| 2021 | 15 | 1,871 | 19,934 | $370,708 | $149,433 |
| 2020 | 20 | 2,199 | 26,321 | $425,067 | $150,665 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 275 | $81,950 | $25,200 | 30.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 74 | $29,674 | $9,824 | 33.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $20,055 | $5,703 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 316 | $62,252 | $22,575 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 67 | $17,755 | $7,270 | 40.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $8,764 | $3,423 | 39.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 189 | 233 | $9,553 | $3,094 | 32.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 112 | 135 | $5,535 | $1,285 | 23.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 155 | 176 | $3,344 | $1,086 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $1,862 | $770.70 | 41.4% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 133 | 166 | $2,822 | $645.45 | 22.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 46 | $3,082 | $430.14 | 14.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 153 | 174 | $1,740 | $387.87 | 22.3% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2022 | 13 | 5,650 | $565.00 | $104.15 | 18.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 338 | 889 | $175,133 | $75,652 | 43.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 140 | 209 | $55,385 | $26,921 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 148 | 148 | $46,324 | $19,017 | 41.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 291 | 635 | $26,035 | $8,337 | 32.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 31 | 31 | $14,477 | $5,065 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 76 | $10,108 | $4,684 | 46.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 187 | 384 | $15,744 | $3,655 | 23.2% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 212 | 463 | $7,871 | $1,794 | 22.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 185 | 263 | $4,997 | $1,620 | 32.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 33 | 126 | $8,442 | $1,323 | 15.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 190 | 282 | $2,820 | $630.00 | 22.3% |
About Dr. Jerry Back, MD
Dr. Jerry Back, MD is a Internal Medicine healthcare provider based in North Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821181868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerry Back, MD has received a total of $602,355 in payments from pharmaceutical and medical device companies, with $302.74 received in 2024. These payments were reported across 1,376 transactions from 63 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($432,722).
As a Medicare-enrolled provider, Back has provided services to 5,330 Medicare beneficiaries, totaling 53,644 services with total Medicare billing of $381,897. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location North Charleston, SC
- Active Since 10/02/2006
- Last Updated 01/14/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1821181868
Products in Payments
- FARXIGA (Drug) $221,835
- Korlym (Drug) $130,428
- Vascepa (Drug) $56,865
- NEXLIZET (Drug) $42,701
- Kerendia (Drug) $36,620
- PRALUENT (Drug) $26,741
- Rybelsus (Drug) $22,751
- PRALUENT ALIROCUMAB INJECTION (Biological) $16,321
- BYDUREON (Drug) $11,289
- NUEDEXTA (Drug) $7,329
- INVOKANA (Drug) $6,568
- Victoza (Drug) $6,048
- NEXLETOL (Drug) $4,269
- RYBELSUS (Drug) $2,067
- PRALUENT (Biological) $1,116
- Omnipod (Device) $661.85
- Ozempic (Drug) $543.03
- V-GO (Device) $364.09
- VRAYLAR (Drug) $328.49
- WATCHMAN (Device) $305.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Charleston
Dr. Darren Sidney, M.d, M.D
Internal Medicine — Payments: $177,289
Patrick Looser, M.d, M.D
Internal Medicine — Payments: $26,213
Jared Intaphan, M.d, M.D
Internal Medicine — Payments: $13,433
Lloyd Hepburn, Md, MD
Internal Medicine — Payments: $5,592
Dr. James Fitzpatrick, D. O, D. O
Internal Medicine — Payments: $4,385
Dr. Marabel Schneider, Md, MD
Internal Medicine — Payments: $4,141